health officials monitor

Health Officials Monitor Arsenic Exposure Risks in Chiang Rai Waterways

ByJustpaste.in

CHIANG RAI – Thailand’s Department of Disease Control (DDC) is expanding its health surveillance program to protect residents living near arsenic-contaminated waterways in Chiang Rai province. Health officials are focusing on individuals facing moderate to high risks of chemical exposure along the Kok, Sai, Ruak, and tributary rivers. This second-year campaign now spans 18 districts to evaluate daily behaviors, collect biological samples, and deliver targeted medical advice.

Key Takeaways

  • Expanded Health Screening: The DDC extended its arsenic exposure monitoring program across 18 districts in Chiang Rai province.
  • Targeted Urine Analysis: Public health teams are conducting risk assessments and gathering urine samples to detect toxic chemical absorption.
  • Proactive Community Guidance: Officials encourage residents to follow local water quality advisories and seek immediate medical care if unusual symptoms occur.

Health Officials Launch Field Operations Across Chiang Rai

Dr. Anek Mungaomklang, Deputy Director-General of the DDC under the Ministry of Public Health, led field operations from July 14 to 16, 2026. Officials gathered at the Rim Kok Health Promoting Hospital in Mueang Chiang Rai district alongside regional healthcare networks. This targeted initiative builds upon baseline health tracking established during the 2025 fiscal year.

Furthermore, medical teams are focusing heavily on workers whose daily livelihoods require direct contact with surface water. Health personnel conduct detailed interviews using official exposure assessment forms to evaluate personal risk factors. Local sub-district hospitals and Village Health Volunteers are coordinating closely to ensure all testing meets academic health standards.

Urine Testing and Environmental Exposure Tracking

Dr. Chantana Padungtod, Director of the Division of Occupational and Environmental Diseases, highlighted the critical need to reach high-risk populations. By pairing behavioral interviews with laboratory urine analysis, public health experts can determine exact contamination levels within human bodies. Consequently, these diagnostic results allow researchers to design effective long-term preventative care measures.

Public health agencies plan to return test results directly to residents along with personalized health recommendations. According to official guidelines from the Department of Disease Control, early monitoring prevents severe health complications associated with heavy metal toxicity. Local authorities continue to track arsenic concentration in surrounding soil, crops, and aquatic life.

The DDC advises all Chiang Rai residents to monitor local announcements regarding water quality and food safety. People living near rivers should refrain from consuming untreated surface water or untested local produce. Anyone experiencing unexplained physical abnormalities should consult a medical professional immediately.

Residents seeking further information can contact the official Department of Disease Control Hotline at 1422 for direct assistance.

Trending News:

Heavy Rains Turn Kok River Dangerously Murky, Sparking Fears in Chiang Rai

Toxic Tides: Rare Earth Mining in Myanmar is Poisoning Chiang Rai’s Rivers

 

Similar Posts

  • |

    Why young minds internalize being a burden

    ByJustpaste.in

    When a child begins to internalize the belief that their presence is an obstacle, the transformation rarely happens in an explosive moment. Instead, it is a gradual, quiet erosion of their sense of self-worth. Recent reports surrounding youth mental health have drawn urgent attention to how children absorb socio-economic pressure, domestic tension, and emotional distress. The youth has convinced themselves that their families would simply be better off without them. Psychological research identifies a specific mindset known as perceived burdensomeness. It’s the distorted cognitive belief that one’s existence imposes an unmanageable drain on loved ones.  Adults often process household stress out loud through financial worries or fatigue. However, children are acute observers but poor interpreters of these adult struggles. When young minds witness prolonged arguments over money, household strain, or family burnout, they frequently externalize the blame onto themselves. Rather than recognizing systemic or situational issues, a child’s natural self-referential worldview leads to a heartbreaking conclusion. If I weren’t here, my parents wouldn’t be so stressed. Triggers for Emotional Withdrawal in Children  Hearing constant worry over basic living costs or healthcare expenses. Feeling as though love or acceptance is tied strictly to high achievement or complete emotional compliance. When overwhelmed caregivers unintentionally treat basic parenting duties as exhausting chores. Receiving persistent feedback that their emotional or physical needs are too much to handle. How Burden Beliefs Manifest in Everyday Behavior Unlike adults, who might voice feelings of worthlessness directly, children express this weight through shifts in conduct. Identifying these subtle indicators early can make the difference between early intervention and severe psychological crisis. From Obligation to Belonging Addressing this internal crisis requires shifting household culture from transactional survival to unconditional emotional safety. Child mental health advocates emphasize that reassurance must go beyond simple verbal praise. It requires active, structural validation within the home. A child needs to know that their value isn’t dependent on their convenience to adults. Love is not a debt they owe back to the family, but a foundation they stand upon. Explicitly reassure children that adult challenges such as bills, jobs, or adult relationships are strictly the responsibility of grown-ups. Validate their requests for help, space, or care as healthy and welcome parts of growing up. Spend unhurried, non-evaluative time together where no performance or chore is expected. Rebuilding a child’s foundational sense of belonging takes consistency, but by recognizing the early signals of perceived burdensomeness, parents and educators can intervene before silence turns into deep-seated trauma.  

  • Genicular Artery Embolization (GAE) for Knee Pain in Thailand

    ByJustpaste.in

    BANGKOK – Persistent osteoarthritis knee pain can make walking, climbing stairs, and everyday activities difficult, even after medication, physical therapy, weight management, or injections. In Thailand, some patients seek an option between ongoing conservative care and total knee replacement, especially when surgery carries added concerns or feels premature. GAE is a minimally invasive, image-guided procedure […]

  • | |

    COVID-19 legal battle against Anthony Fauci

    ByJustpaste.in

    On August 6, 2026, the Senate Homeland Security and Governmental Affairs Committee hold Dr. Anthony Fauci in contempt of Congress. The resolution, driven by the committee’s Republican Chairman, Senator Rand Paul of Kentucky, recommends referring the 85-year-old retired public health official to the U.S. Department of Justice for potential criminal prosecution. The panel’s decision follows a contentious appearance by Fauci during an investigation into the government’s COVID-19 response and the origins of the coronavirus. Throughout the session, Fauci repeatedly invoked his Fifth Amendment constitutional protection against self-incrimination, refusing to answer key questions from lawmakers more than 100 times. A Long-Standing Feud Escalates The bitter confrontation represents the latest chapter in a multi-year rivalry between Rand Paul and Anthony Fauci, who served as the prominent face of the federal government’s pandemic response until his retirement in 2022. For years, Paul and conservative lawmakers have accused Fauci of misrepresenting information regarding the origins of the virus, public health guidance, and funding for viral research. Shortly before the hearing, Paul released over 1,000 pages of Fauci’s personal diary entries, claiming they demonstrated hidden doubts about the origins of the outbreak. During his opening statement at the hearing, Fauci delivered a rebuke of the proceedings, characterizing the hearing as a political trap. He accused Senator Paul of harboring an unhinged obsession with sending him to prison, arguing that the true purpose was to force him into a procedural error or perjury. Citing legal advice from his counsel, Fauci stated that pleading the Fifth Amendment was his only prudent option to protect against politically motivated prosecution, despite his history of testifying before Congress across multiple presidential administrations. The Legal Dilemma Over Clemency and Constitutional Rights At the center of the contempt vote lies a unprecedented constitutional debate involving executive clemency and Fifth Amendment rights. Before leaving office in January 2025, former President Joe Biden issued a preemptive pardon to Fauci covering his official actions between 2014 and early 2025, intending to insulate the scientist from what the former administration deemed politically motivated retributive investigations. Senator Paul argued that because Fauci holds presidential immunity for his past government conduct, he no longer faces real legal exposure for those events, rendering his Fifth Amendment claims invalid. “Holding a witness in contempt is a serious thing, and it should be rare,” Paul remarked prior to the vote. “But the contempt power exists for precisely this circumstance.” Conversely, Democratic members of the committee and legal experts contend that because current lawmakers and political figures have repeatedly threatened Fauci with new criminal proceedings, his apprehension regarding self-incrimination remains legally legitimate. Democrats tried to stall the contempt measure by introducing five procedural motions to table or delay the vote, but the Republican majority defeated every motion along party lines. Potential Next Steps With the committee’s approval, the contempt resolution moves forward, though its future path remains uncertain. Typically, a contempt of Congress resolution requires a full vote on the Senate floor, where it would need a 60-vote threshold to clear procedural hurdles, an unlikely outcome given solid Democratic opposition. However, Chairman Paul indicated he may attempt to bypass a full floor vote by referring the resolution directly to the Department of Justice. Whether the Justice Department chooses to take up the referral and pursue criminal charges against the veteran public health official remains to be seen. Regardless of the legal outcome, today’s vote underscores the persistent political divide in Washington over the scientific, social, and policy decisions made during the COVID-19 pandemic.

  • |

    Common mood-stabilizing drug may offer hope for Alzheimer’s disease

    ByJustpaste.in

      Medical researchers have suggested that lithium, a widely available and inexpensive medication commonly prescribed to treat bipolar disorder and major depressive disorder, may also hold promise as a potential treatment for Alzheimer’s disease. Although the findings are encouraging, scientists stress that much more research is required before lithium can be recommended as a treatment for patients with Alzheimer’s. According to previous studies researchers found that people diagnosed with Alzheimer’s disease tend to have lower levels of lithium in their brains compared to healthy individuals. This observation led scientists to investigate whether restoring lithium levels could help protect the brain from the damage caused by the disease. To explore this possibility, researchers conducted laboratory experiments using mice genetically modified to develop Alzheimer’s disease. The study found that administering very low doses of lithium significantly improved the animals’ memory performance. In addition, the treatment reduced the harmful effects of brain cell damage that are typically associated with Alzheimer’s. These findings suggest that even small amounts of lithium may have protective effects on brain function. Scientists believe lithium works by helping to preserve the health of neurons, the specialized brain cells responsible for memory, learning, and thinking. The drug may also support communication between different regions of the brain by maintaining the connections between nerve cells. Since Alzheimer’s disease gradually destroys these connections, researchers believe lithium could potentially slow the progression of cognitive decline if administered during the early stages of the disease. Further support for this idea comes from a research paper published in the medical journal Translational Psychiatry. In the article, experts emphasized the need for more comprehensive studies to investigate the safety and effectiveness of low-dose lithium therapy for people with early-stage Alzheimer’s disease. They argued that while the initial findings are promising, larger clinical trials involving human participants are essential before any firm conclusions can be drawn. Experts from Alzheimer’s advocacy organizations have also responded cautiously to the research. Dr. Richard Oakley, Director of Research at the Alzheimer’s Society, said the findings contribute to the ongoing scientific discussion about lithium’s potential role in Alzheimer’s treatment. However, he warned that there is currently no conclusive evidence showing that lithium can prevent dementia or serve as a cure for Alzheimer’s disease. Dr. Oakley further explained that the human clinical trials conducted so far have been limited in size and scope. As a result, the available evidence is not yet strong enough to support the routine use of lithium for Alzheimer’s patients. He emphasized that larger, well-designed clinical studies are needed to determine the drug’s long-term benefits, possible side effects, and the most effective dosage. Alzheimer’s disease remains one of the world’s leading causes of dementia, affecting millions of people and placing a significant emotional and financial burden on families and healthcare systems. While current treatments can only help manage symptoms, researchers continue to search for therapies that can slow or stop the disease. If future studies confirm the benefits of low-dose lithium, this affordable and widely available medication could become an important addition to Alzheimer’s treatment. Until then, experts advise patients and caregivers not to use lithium for Alzheimer’s without medical supervision, as scientific evidence is still developing.

  • | |

    UK approves new drug aficamten for thousands of patients

    ByJustpaste.in

    A major breakthrough has been announced in the United Kingdom for thousands of people living with obstructive hypertrophic cardiomyopathy (HCM), a serious heart condition that can significantly affect quality of life. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have simultaneously approved and recommended a new treatment, Aficamten, marketed under the brand name MYQORZO. The decision marks an important milestone in the treatment of obstructive HCM and is expected to benefit around 6,600 patients in England. The coordinated approval process between MHRA and NICE enabled the medicine to become available more quickly than usual, ensuring that eligible patients gain faster access to this innovative therapy. Aficamten is a once-daily oral tablet designed to treat obstructive hypertrophic cardiomyopathy by reducing the excessive contraction of the heart muscle. In people with HCM, the heart muscle becomes abnormally thick, making it harder for the heart to pump blood effectively. This can lead to symptoms such as shortness of breath, chest pain, fatigue, dizziness, fainting, and irregular heart rhythms. By limiting the heart muscle’s excessive contraction, Aficamten improves blood flow from the heart, enhances overall cardiac function, and helps relieve these debilitating symptoms. Clinical trials have shown that Aficamten significantly improves patients’ ability to perform physical activities and reduces many of the common symptoms associated with the disease. Participants experienced better exercise capacity and reported less breathlessness, fatigue, chest discomfort, dizziness, and episodes of abnormal heartbeat. These findings indicate that the medication can substantially improve the quality of life for patients living with obstructive HCM. According to medical experts, the effectiveness of Aficamten is comparable to Mavacamten, another approved treatment for the condition. However, one potential advantage of Aficamten is that patients may require fewer echocardiograms, or heart ultrasound scans, during treatment. This could reduce the need for frequent hospital visits and ongoing monitoring, making treatment more convenient for both patients and healthcare providers. NICE stated that Aficamten was recommended after a comprehensive cost-effectiveness assessment showed that it represents good value for the National Health Service (NHS). The organization also highlighted that close collaboration with the MHRA helped accelerate the review and approval process without compromising safety or effectiveness. Helen Knight, Director of Medicines Evaluation at NICE, described the approval as an important advancement in the treatment of this complex heart disease. She said the new medicine offers fresh hope to patients and expands the range of available treatment options. Julian Beach, Executive Director at the MHRA, said the joint effort between the two organizations demonstrates the importance of collaboration in ensuring that safe and effective medicines reach patients as quickly as possible. The decision has also been welcomed by Cardiomyopathy UK. Chief Executive Katharine McIntosh said the availability of Aficamten would provide patients with more effective treatment options and help improve their overall quality of life. According to NHS England, the new medicine will be available to eligible patients within 30 days of NICE issuing its final guidance. The pharmaceutical company has also agreed to provide the medicine to the NHS at a discounted price, making the treatment more affordable and accessible. The approval represents a significant step forward in the management of obstructive hypertrophic cardiomyopathy and offers renewed hope for thousands of patients across England.

  • A New Lease on Life: Chiang Rai Prachanukroh Hospital Completes Third Kidney Transplant

    ByJustpaste.in

      CHIANG RAI – On August 2, 2026, Chiang Rai Prachanukroh Hospital achieved a major medical milestone. A dedicated team of doctors completed a life-saving kidney transplant for a local patient. The patient had been battling chronic kidney disease and was patiently waiting on the organ transplant registry. This remarkable procedure marks the third successful […]

Leave a Reply

Your email address will not be published. Required fields are marked *